|CANCER & TREATMENTS FOR CANCER CENTER PATIENTS PREVENTION & RISK ASSESSMENT CLINICAL TRIALS & RESEARCH LIVING WITH CANCER|
About Pancreatic Research
Pancreatic cancer is a deadly disease characterized by:
This type of cancer has the worst prognosis of any major malignancy (3% 5 year survival) and is the fourth most common cause of cancer death.
Recent advances in surgical and medical therapy have had little impact on the mortality rate of this disease. Pancreatic cancer is notoriously resistant to many types of cytotoxic chemotherapy and ionizing radiation. The molecular basis of pancreatic cancer is incompletely understood, but the research within the laboratory of Diane Simeone, M.D. is focused to try to understand this terrible disease.
How You Can Help
Learn more about pancreatic cancer research and giving to the program.
U-M Cancer Center gets $10.7M grant to study colon, pancreas cancers